leuprolide

(redirected from Lupron depot-ped)
Also found in: Medical.

leu·pro·lide

 (lo͞o′prō-līd′)
n.
A drug that is a synthetic polypeptide analog of naturally occurring gonadotropin-releasing hormone, C29H84N16O12, used in its acetate form to treat advanced prostate cancer.

Mentioned in ?
References in periodicals archive ?
M2 PHARMA-October 28, 2011-Abbott gets FDA nod to add 18-year long-term data to Lupron Depot-PED label(C)2011 M2 COMMUNICATIONS
28 October 2011 - US Abbott (NYSE:ABT) said on Thursday that a supplemental New Drug Application (sNDA) for Lupron Depot-PED (leuprolide acetate for depot suspension) had been approved by the US Food and Drug Administration (FDA) adding 18-year long-term data to its label.
M2 EQUITYBITES-August 17, 2011-Abbott awarded FDA approval for two new three-month strengths of Lupron Depot-PED for CPP(C)2011 M2 COMMUNICATIONS http://www.
Health care company Abbott (NYSE:ABT) reported on Tuesday the receipt of approval from the US Food and Drug Administration (FDA) for two new strengths for three-month administration of Lupron Depot-PED for the treatment of children with central precocious puberty (CPP).
Broad-based health care company Abbott (NYSE:ABT) announced on Tuesday that the US Food and Drug Administration (FDA) has approved two new strengths for three-month administration of Lupron Depot-PED (leuprolide acetate for depot suspension) for the treatment of children with central precocious puberty (CPP).
17 August 2011 - US drugs and medical devices maker Abbott (NYSE:ABT) said yesterday that the US Food and Drug Administration (FDA) has approved two new strengths for three-month administration of Lupron Depot-PED (leuprolide acetate for depot suspension) for the treatment of children with central precocious puberty (CPP).